Miriam Ayturan

发表

The Use of Clinically Approved Small Particles of Iron Oxide (SPIO) for Labeling of Mesenchymal Stem Cells Aggravates Clinical Symptoms in Experimental Autoimmune Encephalomyelitis and Influences Their In Vivo Distribution

J. Wiskirchen, H. Wolburg, R. Schäfer, 2008, Cell transplantation.

Intranasal delivery of cells to the brain.

W. Frey, C. Gleiter, R. Schäfer, 2009, European journal of cell biology.

Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential.

H. Northoff, B. Neumeister, P. Krause, 2012, Stem cells and development.

Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation

M. Kraus, C. Driessen, H. Overkleeft, 2008, European journal of immunology.

Advanced Intercross Line Mapping Suggests That Ncf1 (Ean6) Regulates Severity in an Animal Model of Guillain-Barré Syndrome1

T. Olsson, M. Jagodic, R. Holmdahl, 2009, The Journal of Immunology.

The use of clinically approved small particles of iron oxide (SPIO) for labeling of mesenchymal stem cells aggravates clinical symptoms in experimental autoimmune encephalomyelitis and influences their in vivo distribution.

J. Wiskirchen, H. Northoff, H. Wolburg, 2008, Cell transplantation.

Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability.

C. Claussen, K. Dietz, J. Wiskirchen, 2009, Cytotherapy.

Expression of blood group genes by mesenchymal stem cells

H. Northoff, W. Flegel, T. Kluba, 2011, British journal of haematology.